StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

China SXT Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2026 it was 21.9%, against 21.1% the year before. The highest annual figure on record is 65.8% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 202621.9%+0.7
FY2025Mar 31, 202521.1%−7.6
FY2024Mar 31, 202428.7%+7.1
FY2023Mar 31, 202321.6%−26.5
FY2022Mar 31, 202248.1%−11.3
FY2021Mar 31, 202159.4%+7.1
FY2020Mar 31, 202052.4%−13.4
FY2019Mar 31, 201965.8%+17.3
FY2018Mar 31, 201848.5%+1.1
FY2017Mar 31, 201747.4%–

More China SXT Pharmaceuticals figures

See a number that looks wrong?